Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest Articles2-Year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry: Beyond the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) study
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 08/24/09
Gyöngyösi M et al. – TAXUS stent implantations with the aim of complete revascularization can be safe for pts with multivessel disease. The multicenter AUTAX (Austrian Multivessel TAXUS-Stent) registry including pts with post- percutaneous coronary intervention (PCI) lesions provides additional information to the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) study.
Methods- AUTAX registry: study of 2-yr clinical/angiographic outcomes of pts with multivessel coronary artery disease after implantation of TAXUS Express stents in a "real-world" setting
- Prospective study of 441 pts (age 64 ± 12 yrs; 78% men; 1,080 lesions) with possible complete revascularization by PCI
- Median clinical follow-up: 753 (quartiles 728-775) days after PCI in 95.7%, with control angiography of 78% at 6 mo
- Primary endpoint: composite of major adverse cardiac (nonfatal acute myocardial infarction [AMI], all-cause mortality, target lesion revascularization [TLR]) and cerebrovascular events (MACCE)
- Cox regression analysis for potential risk factor effects on 2-yr MACCE
- Complete revascularization successful in 90.5%, with left main PCI of 6.8%
- Rates of acute, subacute, and late stent thrombosis: 0.7%, 0.5%, and 0.5%
- On 2-yr follow-up: AMI (1.4%), death (3.6%), stroke (0.2%), and TLR (13.1%), for a composite MACCE of 18.3%
- Binary restenosis rate: 10.8%
- Median of cumulative SYNTAX score: 23.0 (range 12.0-56.5)
- SYNTAX score did not predict TLR or MACCE, due to lack of scoring of restenotic or bypass stenoses (29.8%)
- Significant predictors of 2-year MACCE: age and acute coronary syndrome
- Incomplete revascularization predicted death or AMI
Related Articles
Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09
Relevance Score: 89%
Final 5-Year Results of the TAXUS II Trial. A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions
Circulation, 10/06/09
Relevance Score: 88%
Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients
European Journal of Cardio-Thoracic Surgery, 10/01/09
Relevance Score: 88%
Successful high-risk three vessel coronary intervention in a patient with cardiogenic shock
Intensivmedizin und Notfallmedizin, 10/20/09
Relevance Score: 87%
Early and mid-term clinical outcomes with the CATANIA coronary stent system vs. bare metal stents in patients with coronary artery disease
Cardiovascular Revascularization Medicine, 10/15/09
Relevance Score: 82%
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
Relationship Between Baseline Inflammatory Markers, Antiplate let Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention
Circulation: Cardiovascular Interventions, 11/24/09
Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor